Fingerprint
Dive into the research topics of 'Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma
Melanie B. Thomas, Jeffrey S. Morris, Romil Chadha, Michiko Iwasaki, Harmeet Kaur, Elinor Lin, Ahmed Kaseb, Katrina Glover, Marta Davila, James Abbruzzese
Research output: Contribution to journal › Article › peer-review
306
Citations
(SciVal)